These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21081160)

  • 1. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity.
    Viridén A; Larsson A; Schagerlöf H; Wittgren B
    Int J Pharm; 2010 Nov; 401(1-2):60-7. PubMed ID: 20883761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD; Kuhelj V; Vrečer F; Baumgartner S
    Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of substitution pattern of HPMC on polymer release from matrix tablets.
    Viridén A; Larsson A; Wittgren B
    Int J Pharm; 2010 Apr; 389(1-2):147-56. PubMed ID: 20100556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of source variation on drug release from HPMC tablets: linear regression modeling for prediction of drug release.
    Piriyaprasarth S; Sriamornsak P
    Int J Pharm; 2011 Jun; 411(1-2):36-42. PubMed ID: 21420475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
    Mitchell SA; Balwinski KM
    J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of extended release mini-tablets using directly compressible grades of HPMC.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1690-7. PubMed ID: 23078551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
    Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
    Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
    Contreras L; Melgoza LM; Villalobos R; Caraballo I
    Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.